1.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

2.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

1.

Lyme Borreliosis Serology: A Prospective Cohort Study of Forestry Service Workers in the Netherlands over 8 Years (2008 to 2016) of Follow-Up

2.

Lyme Borreliosis Serology: A Prospective Cohort Study of Forestry Service Workers in the Netherlands over 8 Years (2008 to 2016) of Follow-Up

3.

Lyme Borreliosis Serology: A Prospective Cohort Study of Forestry Service Workers in the Netherlands over 8 Years (2008 to 2016) of Follow-Up

4.

Lyme Borreliosis Serology: A Prospective Cohort Study of Forestry Service Workers in the Netherlands over 8 Years (2008 to 2016) of Follow-Up

5.

Lyme Borreliosis Serology: A Prospective Cohort Study of Forestry Service Workers in the Netherlands over 8 Years (2008 to 2016) of Follow-Up

1.

Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis : a prospective cohort study in Belgium (2016–2020)

2.

Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis : a prospective cohort study in Belgium (2016–2020)

1.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

2.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

3.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

4.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

5.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

6.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

7.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

8.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

9.

Tick-borne diseases in Belgium : the incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections

1.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

2.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

3.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

4.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

5.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

6.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

7.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

8.

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

1.

Determinants and protective behaviours regarding tick bites among school children in the Netherlands: a cross-sectional study

2.

Determinants and protective behaviours regarding tick bites among school children in the Netherlands: a cross-sectional study

1.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

2.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

3.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

4.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

5.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

1.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

2.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

3.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

4.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

5.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

6.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

7.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

8.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

9.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

1.

Prevalence of pathogens in ticks collected from humans through citizen science in Belgium

2.

Prevalence of pathogens in ticks collected from humans through citizen science in Belgium

1.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

2.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

3.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

4.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

5.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

6.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

7.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017